Imeglimin as a Replacement Therapy for Metformin in Patients With Type 2 Diabetes Mellitus Experiencing Metformin Intolerance: A Retrospective Observational Study
Cureus · 03.06.2026
DOI: 10.7759/cureus.110200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 03.06.2026. Verfasst von Debmalya Sanyal und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Public Health, The Newcastle University, Newcastle, AUS. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine and Public Health, The Newcastle University, Newcastle, AUS.
- Endocrinology, Narayana Health Rabindranath Tagore International Institute of Cardiac Sciences (NH RTIICS), Kolkata, IND.
- Endocrinology, Kali Prasad Chowdhury (KPC) Medical College and Hospital, Kolkata, IND.
- Pharmacology, Zydus Healthcare Limited, Mumbai, IND.
Zitieren
APA
Sanyal, D., & Deb, R. B. (2026). Imeglimin as a Replacement Therapy for Metformin in Patients With Type 2 Diabetes Mellitus Experiencing Metformin Intolerance: A Retrospective Observational Study. Cureus. https://doi.org/10.7759/cureus.110200
Vancouver
Sanyal D, Deb RB. Imeglimin as a Replacement Therapy for Metformin in Patients With Type 2 Diabetes Mellitus Experiencing Metformin Intolerance: A Retrospective Observational Study. Cureus. 2026. doi:10.7759/cureus.110200
BibTeX
@article{Sanyal2026,
author = {Sanyal, Debmalya and Deb, Rituraj B},
title = {Imeglimin as a Replacement Therapy for Metformin in Patients With Type 2 Diabetes Mellitus Experiencing Metformin Intolerance: A Retrospective Observational Study},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.110200}
}
EUVIMED